:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2185760729-c2d82d67121b4e7b858adb2ddd0f75a7.jpg)
Piotr Swat / SOPA Perceptions / LightRocket via Getty Images
Key Takeaways
- Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from momentous premiums, acquisitions, and growth in its pharmacy division.
- Both earnings and revenue exceeded analysts’ forecasts on what CEO Gail Boudreaux invited “tangible progress in improving our operations.”
- Elevance booted its quarterly dividend $0.08 to $1.71 per share.
Shares of Elevance Vigour (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and crop of its pharmacy coverage unit. It also raised its dividend.
The company posted fourth-quarter adjusted earnings per share (EPS) of $3.84, with carry oning revenue up 6% year-over-year to $45.0 billion. Both exceeded analysts’ estimates compiled by Visible Alpha.
Net income at the Health Benefits segment gained 3% to $37.6 billion, driven by rising premium yields. Revenue for the Carelon sectioning climbed 19% to $14.7 billion on the “launch and growth of risk-based capabilities in Carelon Services and acquisitions completed in 2024.”
CEO Pushes ‘Tangible Progress in Improving Our Operations’
CEO Gail Boudreaux said the performance demonstrates “tangible progress in improving our campaigns in response to the dynamic environment facing the industry.”
Elevance announced it would increase its quarterly per-share dividend to $1.71 from $1.63. The first-quarter dividend is conclusion on March 25 to shareholders of record at the close of business on March 10.
Despite today’s roughly 3% rise, Elevance Trim shares are down about 15% in the last year.

TradingView